GlobeNewswire
Immutep Reports Progress from Phase I Study of LAG-3 Agonist for Autoimmune Diseases
📈
AI Sentiment
Highly Positive
9/10
Immutep Limited News
Latest updates and market news for IMMP
1 news
Mar 18 - Mar 24, 2026
Page 1
Share this news page